Malaria News and Research

Latest Malaria News and Research

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

The Institute for OneWorld Health (iOWH) announced a major milestone in the fight against cholera. The Food and Drug Administration (FDA) granted iOWH permission to begin phase 1 trials for iOWH032, a drug to treat secretory diarrhea. This is the first submission of an Investigational New Drug application for a completely new chemical entity by a non-profit of this size to receive such rapid FDA clearance, and it could be the first synthetic drug of its kind for diarrheal diseases.

2 Mar 2011

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

VaxInnate Corporation today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, worth up to $196 million to fund the development of recombinant seasonal and pandemic flu vaccines.

1 Mar 2011

U.K.'s DFID might reduce funding for FAO in light of 'patchy' performance

The U.K.'s Department for International Development on Saturday said it might reduce its contribution to the U.N. Food and Agriculture Organization if the agency does not improve its performance, Reuters reports.

1 Mar 2011

NIH-funded study finds way to reduce transmission of malaria to humans

Spraying malaria-transmitting mosquitoes with a genetically modified fungus can kill the malaria parasite without harming the mosquito, potentially reducing malaria transmission to humans, according to a new study published in the journal Science. Funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the study was led by Raymond J. St. Leger, Ph.D., of the University of Maryland, College Park.

25 Feb 2011

Journal of Clinical Virology publishes positive outcome from CMX001 treatment against AdV infection

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of the first reported case in which adenovirus infection was successfully eradicated following treatment with its broad-spectrum antiviral drug, CMX001.

25 Feb 2011

Transgenic fungal approach can fight against malaria and bug-borne diseases

New findings by a University of Maryland-led team of scientists indicate that a genetically engineered fungus carrying genes for a human anti-malarial antibody or a scorpion anti-malarial toxin could be a highly effective, specific and environmentally friendly tool for combating malaria, at a time when the effectiveness of current pesticides against malaria mosquitoes is declining.

24 Feb 2011

Opinions: Foreign aid lessons from Britain; food security; Global Fund investigation; U.S. food aid cuts; Africa needs trade

"Before Republican budget hawks wield their knife, ... they should take a lesson from their conservative cousins in the United Kingdom: When belt-tightening gets serious, foreign aid should be improved, not gutted," according to an opinion piece in the New Republic written by Thomas Carothers, vice president for studies at the Carnegie Endowment for International Peace.

24 Feb 2011

Daily report global health conversations: Health sector corruption

Recent media reports have drawn attention to an internal audit that revealed several countries' misuse of Global Fund to Fight AIDS, Tuberculosis and Malaria grant money, totaling $34 million.

24 Feb 2011

Antiepileptic drugs could make HIV drugs less effective

A Michigan State University researcher is looking to uncover the risks of treating seizures in HIV-positive patients, providing much-needed data on possible interactions between antiepileptic drugs and antiretroviral medicines that potentially could make HIV drugs less effective or the disease itself drug resistant.

23 Feb 2011

New nanoparticle can help develop vaccines against HIV, malaria

MIT engineers have designed a new type of nanoparticle that could safely and effectively deliver vaccines for diseases such as HIV and malaria.

23 Feb 2011

Tropical seaweed's antifungal chemical cues may have promising antimalarial properties for humans

A group of chemical compounds used by a species of tropical seaweed to ward off fungus attacks may have promising antimalarial properties for humans. The compounds are part of a unique chemical signaling system that seaweeds use to battle enemies - and that may provide a wealth of potential new pharmaceutical compounds.

22 Feb 2011

Canada Scholar presents research on link between cities and water-related diseases at AAAS conference

Despite clean water and improved public services, water-related diseases continues to spread in cities around the world. Vanier Canada Graduate Scholar Kate Mulligan presents her research on the connection between cities, water and health at the THINK CANADA Press Breakfast at the American Association for the Advancement of Science conference Sunday.

21 Feb 2011

Scientists use synthetic oil for dispersing pathogenic fungi to prevent malaria spread

There are over 200 million cases of malaria each year and, according to the World Health Organisation, in 2009 malaria was responsible for 781,000 deaths worldwide. Malaria is spread by mosquitoes which breed in open water and spend much of their larval stage feeding on fungi and microorganisms at the water surface.

20 Feb 2011

Watson's performance on Jeopardy! inspires 700% spike in volunteers for World Community Grid

Watson wasn't the only computer system that won this week when it competed successfully against two human champions on the Jeopardy! game show.

19 Feb 2011

GIBH, Saint Louis University form global research partnership to combat malaria

The Center for World Health & Medicine at Saint Louis University and China's Guangzhou Institutes of Biomedicine and Health are forming a global research partnership that initially will focus on new treatments for malaria.

19 Feb 2011

New tuberculosis vaccine provides better protection

Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.

19 Feb 2011

Scientists investigate natural chemical compound in sea sponges to create novel anti-cancer drugs

Scientists in London are turning to sea sponges to help them learn more about anti-cancer drugs. Using his £106,079 grant from the Association for International Cancer Research Dr Matthew Fuchter and his team are investigating a naturally-occurring chemical found in the sea sponge.

18 Feb 2011

Media examines foreign aid stakeholders' reactions to FY11, FY12 budgets

In the wake of President Barack Obama's fiscal year 2012 budget proposal and the negotiation of the fiscal year 2011 budget bill in the House of Representatives, news outlets looked at stakeholders' responses to the measures and analyzed different pieces of the bills.

18 Feb 2011

Daily Report Global Health Conversations: Global health funding and the FY11, FY12 budgets

As Congress considers both the FY11 and FY12 budgets, the Kaiser Daily Global Health Policy Report's Jaclyn Schiff spoke to Adam Wexler, a senior policy analyst for global health policy at the Kaiser Family Foundation, about the potential implications for global health funding.

18 Feb 2011

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

"A rise in global funding for research into neglected diseases needs to be matched by a continued focus on delivering practical new ways to curb sickness in the developing world," according to the third annual report by the Global Funding of Innovation for Neglected Diseases released on Wednesday, Reuters reports.

18 Feb 2011

Malaria News and Research

Latest Malaria News and Research

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

U.K.'s DFID might reduce funding for FAO in light of 'patchy' performance

NIH-funded study finds way to reduce transmission of malaria to humans

Journal of Clinical Virology publishes positive outcome from CMX001 treatment against AdV infection

Transgenic fungal approach can fight against malaria and bug-borne diseases

Opinions: Foreign aid lessons from Britain; food security; Global Fund investigation; U.S. food aid cuts; Africa needs trade

Daily report global health conversations: Health sector corruption

Antiepileptic drugs could make HIV drugs less effective

New nanoparticle can help develop vaccines against HIV, malaria

Tropical seaweed's antifungal chemical cues may have promising antimalarial properties for humans

Canada Scholar presents research on link between cities and water-related diseases at AAAS conference

Scientists use synthetic oil for dispersing pathogenic fungi to prevent malaria spread

Watson's performance on Jeopardy! inspires 700% spike in volunteers for World Community Grid

GIBH, Saint Louis University form global research partnership to combat malaria

New tuberculosis vaccine provides better protection

Scientists investigate natural chemical compound in sea sponges to create novel anti-cancer drugs

Media examines foreign aid stakeholders' reactions to FY11, FY12 budgets

Daily Report Global Health Conversations: Global health funding and the FY11, FY12 budgets

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Malaria News and Research

Latest Malaria News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in